BSE Prices delayed by 5 minutes ! Prices as on   May 07, 2025 - 3:59PM   

MARKETS

News Details

( As on 06/05/2025 13:50)

Alembic Pharmaceutic Q4 net profit down 62.68% at Rs 75.34 cr

The company reported standalone net profit of Rs 75.34 crore for the quarter ended March 31, 2025 as compared to Rs 201.87 crore in the same period last year, registering a year-on-year decline of 62.68 per cent.

Net revenue of the company rose moderately by 6.52 per cent at Rs 1,570.64 crore in January-March quarter of this fiscal as against Rs 1,474.55 crore in the corresponding period last year.

During January-March quarter, operating expenses increased by 18.01 per cent to Rs 1,399.98 crore from Rs 1,186.36 crore in year ago period.

Other Income grew by 82.96 per cent at Rs 13.21 crore versus (Mar'24 Rs 7.22 crore).

Operating Profit slipped by 40.78 per cent to Rs 170.66 crore as against Rs 288.19 crore in the year ago period, while Operating Profit Margin (OPM) contracted year-on-year to 44.37 per cent in March quarter.

Interest grew by 134.06 per cent y-o-y to Rs 23.71 crore, while Taxation increased by 13.51 per cent at Rs 16.22 crore (Mar'24 Rs 14.29 crore).